radionuclides decay emission attractive certain radioimmunotherapeutic applications include treatment lymphomas compartmentally spread malignancies ovarian cancer neoplastic meningitis micrometastatic disease radionuclides purpose 212bi NUMBER min half life 211at NUMBER hr half life compared commonly used radiotherapy 212bi 211at higher energy shorter range NUMBER microm considerably higher linear energy transfer preliminary results obtained variety vitro systems vivo models documented exquisite toxicity established basis initiating radiotherapy trials humans monoclonal antibodies labeled radionuclides references NUMBER alpha particles alpha emitting beta emitters alpha particles alpha particles alpha emitting